Protective Effects of Dabrafenib on Doxorubicin-Induced Cardiotoxicity in Rats
Year: 2026
Type: article
Abstract: Doxorubicin (DOX) is a commonly used antineoplastic agent whose clinical use is mainly limited by its cardiotoxicity. Since necroptosis has been implicated in DOX-induced cardiotoxicity, this study investigated and compared the protective effects of dabrafenib (Dab), a RIPK3 inhibitor, and necrostatin-1 (Nec-1), a RIPK1 inhibitor, targeting two key components of the necroptotic signaling pathway. Thirty-six male Sprague–Dawley rats were divided into four groups: control, DOX, DOX+Dab, and DOX+Nec-1. Coronary perfusion pressure was assessed in isolated hearts using the Langendorff system, while serum creatine kinase (CK) and lactate dehydrogenase (LDH) levels, cardiac malondialdehyde (MDA) levels, histopathological alterations, and the expression of necroptosis-related proteins were analyzed. DOX treatment significantly increased coronary perfusion pressure, serum CK and LDH levels, cardiac MDA levels, and RIPK1, RIPK3, and mixed lineage kinase domain-like protein (MLKL) expression and induced marked histopathological damage. Both dabrafenib and Nec-1 attenuated these alterations and histopathological damage, although the magnitude of their effects varied across the measured outcomes. No significant differences in serum CK or LDH levels were observed between the two treatment groups. Overall, our findings suggest that dabrafenib may attenuate DOX-induced cardiac injury, although its effects on necroptotic signaling remain to be established.
Source: Biology
Authors: Meryem Şeyda Kaya(Conceptualization, Formal analysis, Investigation, Methodology, Writing – original draft, Writing – review & editing), Meral Erdinç(Conceptualization, Funding acquisition, Investigation, Methodology, Project administration, Supervision, Writing – review & editing), Zeynep Erdoğmuş Özgen(Formal analysis, Investigation, Methodology), İlker Kelle(Investigation, Methodology), Fesih Aktar(Investigation, Methodology), Levent Erdinç(Investigation, Methodology), Ayşe Nur Keleş(Investigation, Methodology), Mehmet Küçüköner(Investigation, Methodology)
Institution: Dicle University
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,258
Funder: Dicle Üniversitesi
OpenAlex ID: W7236812912
